SZ 161 (Ropinirole Hydrochloride Extended-Release 8mg)
Pill with imprint SZ 161 is Brown, Capsule-shape and has been identified as Ropinirole Hydrochloride Extended-Release 8mg. It is supplied by Sandoz Inc..
Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 8mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SZ 161
Ropinirole Hydrochloride Extended-Release
- Imprint
- SZ 161
- Strength
- 8mg
- Color
- Brown
- Size
- 13.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Inc.
- National Drug Code (NDC)
- 00781-5786
- Inactive Ingredients
-
silicon dioxide,
hydrogenated castor oil,
hydroxypropyl cellulose (type h),
hypromelloses,
ferric oxide red,
lactose anhydrous,
magnesium stearate,
magnesium silicate,
polyethylene glycol,
ferrosoferric oxide,
titanium dioxide,
diethyl phthalate,
maltodextrin,
ferric oxide yellow,
ethylcelluloses
Note: Inactive ingredients may vary.
More about ropinirole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 289 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- FDA Alerts (1)
Consumer resources
- Patient Information
- Ropinirole (Advanced Reading)
- Ropinirole Extended-Release Tablets
- Ropinirole Tablets
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.